ŌURA, the company behind the leading smart ring, Oura Ring, announced today that it has completed a $200 million Series D funding round. Fidelity Management & Research Company and Dexcom, the global leader in glucose biosensing, participated in the round, which raised the company’s valuation to $5.2 billion.
This funding reflects ŌURA’s momentum in building and leading the smart ring category. And this new funding will enable ŌURA to expand its product offerings, advance further investment in product, science, and healthcare innovation like AI, advance global expansion efforts, and explore more acquisitions to accelerate growth.
This funding milestone follows a time of notable growth for ŌURA. The company recently surpassed 2.5 million rings sold and has seen its member base and revenue more than double over the past year.
This year, ŌURA expanded its retail presence globally with new retail partnerships such as Amazon and Target. It grew its commercial business with expanded military partnerships, including the Naval Health Research Center (NHRC), the Air Force, and the Defense Innovation Unit. Plus, ŌURA recently announced the acquisitions of Sparta Science and Veri, a first-of-its-kind partnership with Medicare Advantage provider Essence Healthcare, and a strategic metabolic-health partnership with Dexcom.
Since being founded in 2013, ŌURA has been redefining the future of health wearables. The company recently introduced the next-generation Oura Ring 4, providing an unparalleled degree of accuracy, comfort, and personalization through its breakthrough Smart Sensing technology. And ŌURA has continued to expand its product capabilities from its core Sleep and Activity pillars to include a broader range of health use cases, including Heart Health, Stress & Resilience, and Women’s Health.
KEY QUOTES:
“As we continue to drive momentum and growth, we are bolstered by the additional support of these investors. We’ve made significant progress in advancing our mission to make health a daily practice and will use this funding to unlock new opportunities, with AI development at the center of our strategy. We know that ŌURA has the potential to change lives at scale, and we’re excited to continue leading the market in innovation while pursuing opportunities that extend beyond the ring.”
“Wearable tech is for anyone who wants to better understand the state of their health and live more optimally, for longer. We’re committed to continuing our relentless pace of innovation and delivering exceptional value to Oura Members, and this new round of funding will enable us to do just that.”
- Tom Hale, ŌURA chief executive officer
